• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Robert J. D'Amato, MD, PhD


  • Adini I, Ghosh K, Adini A, Chi ZL, Yoshimura T, Benny O, Connor KM, Rogers MS, Bazinet L, Birsner AE, Bielenberg DR, D'Amato RJ.Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment.J Clin Invest. 2014 Jan 2;124(1):425-36.
  • D'Amato RJ, Lentzsch S, Rogers MS.Pomalidomide is strongly antiangiogenic and teratogenic in relevant animal models.Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):E4818.
  • Rogers MS, Adini I, McBride AF, Birsner AE, D'Amato RJ.The albino mutation of tyrosinase alters ocular angiogenic responsiveness.Angiogenesis. 2013 Feb 20.
  • Xu H, Zhang T, Man GC, May KE, Becker CM, Davis TN, Kung AL, Birsner AE, D'Amato RJ, Wong AW, Wang CC.Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.Angiogenesis. 2013 Jan 19.
  • Adini A, Adini I, Ghosh K, Benny O, Pravda E, Hu R, Luyindula D, D'Amato RJ.The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action.Angiogenesis. 2012 Nov 13.
  • Rogers MS, D'Amato RJ.Common polymorphisms in angiogenesis.Cold Spring Harb Perspect Med. 2012;2(11).
  • Becker CM, Beaudry P, Funakoshi T, Benny O, Zaslavsky A, Zurakowski D, Folkman J, D'Amato RJ, Ryeom S.Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.Am J Pathol. 2011 Apr;178(4):1782-91.
  • Erba P, Ogawa R, Ackermann M, Adini A, Miele LF, Dastouri P, Helm D, Mentzer SJ, D'Amato RJ, Murphy GF, Konerding MA, Orgill DP.Angiogenesis in Wounds Treated by Microdeformational Wound Therapy.Ann Surg. 2011 Jan 6.
  • Benny O, Nakai K, Yoshimura T, Bazinet L, Akula JD, Nakao S, Hafezi-Moghadam A, Panigrahy D, Pakneshan P, D'Amato RJ.Broad spectrum antiangiogenic treatment for ocular neovascular diseases.PLoS ONE. 2010;5(9).
  • Nakai K, Fainaru O, Bazinet L, Pakneshan P, Benny O, Pravda E, Folkman J, D'Amato R.Dendritic cells augment choroidal neovascularization.Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3666-70.
  • Benny O,Fainaru O,Adini A,Cassiola F,Bazinet L,Adini I,Pravda E,Nahmias Y,Koirala S,Corfas G,D'Amato RJ,Folkman J.An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.Nat Biotechnol. 2008 Jul;26(7):799-807.
  • Becker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner A, Folkman J, D'Amato RJ.2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.Am J Pathol. 2008 Feb;172(2):534-44.
  • Rogers MS, Christensen KA, Birsner AE, Short SM, Wigelsworth DJ, Collier RJ, D'Amato RJ.Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.Cancer Res. 2007 Oct 15;67(20):9980-5.
  • Fainaru O, Adini A, Benny O, Adini I, Short S, Bazinet L, Nakai K, Pravda E, Hornstein MD, D'Amato RJ, Folkman J.Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis.FASEB J. 2008 Feb;22(2):522-9.
  • Becker CM, D'Amato RJ.Angiogenesis and antiangiogenic therapy in endometriosis.Microvasc Res. 2007 Sep-Nov;74(2-3):121-30. Review.
  • D'Amico AV, Renshaw AA, Sussman B, Chen MH.Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy.JAMA. 2005 Jul 27;294(4):440-7.
  • D'Amato RJ, Lentzsch S, Anderson KC, Rogers MS.Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma.Semin Oncol. 2001 Dec;28(6):597-601.
  • Punglia RS, Lu M, Hsu J, Kuroki M, Tolentino MJ, Keough K, Levy AP, Levy NS, Goldberg MA, D'Amato RJ, Adamis AP.Regulation of vascular endothelial growth factor expression by insulin-like growth factor I.Diabetes. 1997 Oct;46(10):1619-26.
  • Kenyon BM, Browne F, D'Amato RJ.Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization.Exp Eye Res. 1997 Jun;64(6):971-8.
  • Klauber N, Rohan RM, Flynn E, D'Amato RJ.Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470.Nat Med. 1997 Apr;3(4):443-6.
  • Klauber N, Parangi S, Flynn E, Hamel E, D'Amato RJ.Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.Cancer Res. 1997 Jan 1;57(1):81-6.
  • Klauber N, Browne F, Anand-Apte B, D'Amato RJ.New activity of spironolactone. Inhibition of angiogenesis in vitro and in vivo.Circulation. 1996 Nov 15;94(10):2566-71.
  • Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ.A model of angiogenesis in the mouse cornea.Invest Ophthalmol Vis Sci. 1996 Jul;37(8):1625-32.
  • Hamel E, Lin CM, Flynn E, D'Amato RJ.Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers.Biochemistry. 1996 Jan 30;35(4):1304-10.
  • D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E.2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3964-8.
  • D'Amato RJ, Loughnan MS, Flynn E, Folkman J.Thalidomide is an inhibitor of angiogenesis.Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4082-5.
  • Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA.Oxygen-induced retinopathy in the mouse.Invest Ophthalmol Vis Sci. 1994 Jan;35(1):101-11.
  • D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH.Aminergic systems in Alzheimer's disease and Parkinson's disease.Ann Neurol. 1987 Aug;22(2):229-36.
  • D'Amato RJ, Largent BL, Snowman AM, Snyder SH.Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.J Pharmacol Exp Ther. 1987 Jul;242(1):364-71.
  • D'Amato RJ, Blue ME, Largent BL, Lynch DR, Ledbetter DJ, Molliver ME, Snyder SH.Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas.Proc Natl Acad Sci U S A. 1987 Jun;84(12):4322-6.
  • D'Amato RJ, Benham DF, Snyder SH.Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin.J Neurochem. 1987 Feb;48(2):653-8.
  • D'Amato RJ, Lipman ZP, Snyder SH.Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.Science. 1986 Feb 28;231(4741):987-9.
  • Snyder SH, D'Amato RJ.MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture.Neurology. 1986 Feb;36(2):250-8.
  • Snyder SH, D'Amato RJ.Predicting Parkinson's disease.Nature. 1985 Sep 19-25;317(6034):198-9.
  • Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH.Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.Proc Natl Acad Sci U S A. 1985 Apr;82(7):2173-7.
  • Holaday JW, D'Amato RJ.Multiple opioid receptors: evidence for mu-delta binding site interactions in endotoxic shock.Life Sci. 1983;33 Suppl 1:703-6.
  • Holaday JW, D'Amato RJ.Naloxone and ischemic neurologic deficits in the gerbil: is there an effect?.Science. 1982 Nov 5;218(4572):592-4.
  • Holaday JW, D'Amato RJ, Faden AI.Thyrotropin-releasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock.Science. 1981 Jul 10;213(4504):216-8.